𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma : A Phase II multicenter trial

✍ Scribed by Vera Hirsh; Adrian Langleben; Joseph Ayoub; Yvon Cormier; Javier Pintos; José L. Iglésias

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
85 KB
Volume
92
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and vinorelbine in advanced
Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma : A Phase II study
✍ Rogerio Lilenbaum; Roberto Cano; Michael Schwartz; Leonard Siegel; Jose Lutzky; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

The authors conducted a Phase II study to evaluate the activity of the combination of gemcitabine and vinorelbine in patients with advanced nonsmall cell lung carcinoma (NSCLC). ## METHODS. Patients were eligible if they had Stage IIIB (malignant pleural effusion) or Stage IV NSCLC, no prior chemo

A phase I/II trial of neoadjuvant chemot
A phase I/II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated irradiation for patients with inoperable nonsmall cell lung carcinoma
✍ Jean Viallet; Marc-André Brassard; Luis Souhami; Joseph Ayoub; Pierre Del Vecchi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## BACKGROUND. Both locoregional and distant disease control remains poor in the treatment of Stage III nonsmall cell lung carcinoma (NSCLC). This trial was conducted to evaluate the tolerance and responses of patients with NSCLC given a neoadjuvant regimen of cisplatin and vinorelbine chemotherapy

Vinorelbine in elderly patients with ino
Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma : A Phase II study
✍ Gianfranco Buccheri; Domenico Ferrigno 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## BACKGROUND. Cancer in the elderly is becoming a complex and frequent issue. At least 30% of lung carcinomas are expected to arise each year in elderly patients, who often have significant comorbidity. The most appropriate treatment for this large portion of cancer patients remains unknown. The

Phase I trial of docetaxel and vinorelbi
Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma
✍ Vincent A. Miller; Kenneth K. Ng; Lee M. Krug; Wendy Perez; Barbara Pizzo; Rober 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Background: With preclinical evidence of synergy, this dose-finding trial examining the combination of docetaxel and vinorelbine given with prophylactic filgrastim for the treatment of patients with nonsmall cell lung carcinoma was undertaken. ## Methods: Twenty-seven patients with advanced no